Method for determining encapsulation efficiency of vitamin K1 injection
Patent Information
- Application Number
- CN202411112621.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-14
- Publication Date
- 2024-12-03
Smart Images

Figure CN119064492A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of encapsulation rate determination, and specifically relates to a method for determining the encapsulation rate of vitamin K1 injection. Background Art
[0002] Vitamin K1 is a fat-soluble vitamin, mainly used to treat hypoprothrombinemia, vitamin K deficiency, and can also prevent and treat neonatal hemorrhagic disease. Currently, the main routes of administration of vitamin K1 include oral, intramuscular, subcutaneous and intravenous injections. However, since vitamin K1 is almost insoluble in water, when vitamin K1 injection is initially prepared, emulsifiers are often added to increase the solubility of vitamin K1 in water, but the addition of emulsifiers often causes severe allergic reactions.
[0003] Mixed micelles composed of bile salts and phospholipids are a new type of drug delivery system with high biosafety. They can avoid the use of emulsifiers or solubilizers, reducing the risk of allergic reactions. However, researchers found that the vitamin K1 mixed micelle solution still had adverse reactions during clinical application. The researchers speculated that this may be caused by free vitamin K1 in the injection. For example, free vitamin K1 can activate the release of vasodilators through the nitric oxide pathway and block the main ion current, which has a direct effect on the cardiac action potential. When injected intravenously, it can lead to hemodynamic changes and cause adverse reactions such as cardiovascular failure. Therefore, the encapsulation rate of vitamin K1 injection (mixed micelles) is an important evaluation indicator affecting biosafety.
[0004] At present, the detection method of the encapsulation rate of vitamin K1 injection (mixed micelle) mainly includes dialysis and ultrafiltration centrifugation. Among them, the dialysis method needs to use a large amount of dialysis solution. Because the vitamin K1 injection itself is a mixed micelle, when a large amount of dialysate is used for dialysis, the micellar structure of the vitamin K1 injection itself will be destroyed, causing vitamin K1 to leak from the micelle into the dialysate, thereby being unable to achieve accurate determination of the encapsulation rate. The ultrafiltration centrifugation method generally uses an ultrafiltration tube with different molecular weight cutoffs, and the particle size distribution of the mixed micelles in the vitamin K1 injection is mainly around 1.5nm and 30nm, wherein the mixed micelles with a particle size of about 1.5nm cannot currently be completely intercepted by a suitable ultrafiltration tube, and the ultrafiltration membrane used during filtration adsorbs the vitamin K1 injection, which also causes the encapsulation rate to be unable to achieve accurate determination. Summary of the invention
[0005] In view of this, the present invention provides a method for determining the encapsulation rate of vitamin K1 injection. The method combines resin adsorption and centrifugation to achieve good separation of free vitamin K1 and micellar layer in the vitamin K1 injection, thereby achieving accurate determination of the encapsulation rate of the vitamin K1 injection.
[0006] In order to solve the above technical problems, the first aspect of the present invention provides a method for determining the encapsulation efficiency of vitamin K1 injection, comprising the steps of:
[0007] S1, separation step: adding a non-polar macroporous adsorption resin to the vitamin K1 injection to be tested, mixing and centrifuging, so that the vitamin K1 injection is sequentially separated into a "viscous droplet" layer, a micelle layer and a resin layer from top to bottom;
[0008] S2. Determination step: Using liquid chromatography, the micellar layer and the unseparated vitamin K1 injection are measured respectively, and the area A of the chromatographic peak is 胶束 and A 总 Perform the calculation:
[0009] Encapsulation efficiency (%) = A 胶束 / A 总 ×100%,
[0010] A 胶束 is the chromatographic peak area of the micelle layer, A 总 is the chromatographic peak area of unseparated vitamin K1 injection.
[0011] In order to accurately measure the encapsulation rate of vitamin K1 injection (excluding the influence of vitamin K1 free in water on the determination of vitamin K1 encapsulated in micelles), the inventors have successfully separated the vitamin K1 free in water from the micelle layer in the vitamin K1 injection to be tested by ingenious design, using a combination of non-polar macroporous adsorption resin and centrifugation. The micelle layer obtained after separation and the unseparated vitamin K1 injection are measured by liquid chromatography, and the encapsulation rate of vitamin K1 injection can be accurately calculated based on the respective chromatographic peak areas.
[0012] In combination with the first aspect, the non-polar macroporous adsorption resin is selected from at least one of D101 non-polar macroporous adsorption resin, HPD-100 non-polar macroporous adsorption resin, ADS-8 non-polar macroporous adsorption resin or HJ-04 non-polar macroporous adsorption resin.
[0013] In combination with the first aspect, the mass volume ratio of the non-polar macroporous adsorption resin to the vitamin K1 injection to be tested is 200-800 mg: 5 mL. This ratio range can ensure that the "molecular" vitamin K1 slightly soluble in water is fully adsorbed, and the addition of the adsorption resin will not affect the distribution of vitamin K1 in the micelle layer and the "viscous droplet" layer dispersed in water.
[0014] In combination with the first aspect, vortex oscillation is used for mixing. Vortex oscillation can make the non-polar macroporous adsorption resin more evenly dispersed in the injection solution, thereby ensuring a good adsorption effect.
[0015] In combination with the first aspect, the centrifugation time is at least 15 minutes, preferably 20 to 30 minutes.
[0016] In combination with the first aspect, the rotation speed during centrifugation is 10000-20000 r / min.
[0017] In combination with the first aspect, the resin layer adsorbs "molecular" vitamin K1 that is slightly soluble in water.
[0018] In combination with the first aspect, the liquid chromatography method adopts the following chromatographic conditions:
[0019] Chromatographic column: C18 column;
[0020] Mobile phase: anhydrous ethanol: water = 90:10, v / v;
[0021] Detection wavelength: 254nm;
[0022] Column temperature: 30°C;
[0023] Flow rate: 1 mL / min;
[0024] Injection volume: 10 μL.
[0025] In combination with the first aspect, the model of the C18 chromatographic column is Agilent ZORBAX Eclipe XDB-C18, 4.6×150 mm, 5 μm.
[0026] The second aspect of the present invention provides an application of the above method for determining the encapsulation efficiency of vitamin K1 injection in screening and monitoring the preparation process of vitamin K1 injection.
[0027] The method for determining the encapsulation rate of vitamin K1 injection provided by the present invention can achieve good separation of free vitamins (including "molecular" vitamin K1 that is slightly soluble in water and "viscous droplet" vitamin K1 that is directly dispersed in water due to insolubility) and micellar layers in vitamin K1 injection, thereby achieving accurate determination of the encapsulation rate of vitamin K1 injection, providing an important means for ensuring the safe production and quality control of vitamin K1 injection. Moreover, the determination method provided by the present invention is simpler to operate than the existing dialysis method and ultrafiltration centrifugation method, and the test efficiency is significantly improved. BRIEF DESCRIPTION OF THE DRAWINGS
[0028] Figure 1 To verify the chromatogram of the blank solvent in Example 2;
[0029] Figure 2 The chromatogram of the blank excipient solution in Verification Example 2;
[0030] Figure 3This is the chromatogram of the vitamin K1 reference solution in Verification Example 2. DETAILED DESCRIPTION
[0031] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with specific embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.
[0032] The Pharmacopoeia 2020 records that the properties of vitamin K1 are a yellow to orange clear viscous liquid that is insoluble in water (according to the Pharmacopoeia, "insoluble" means a solubility in water of less than 0.1 mg / mL). It can be seen that the solubility of vitamin K1 in water is only less than 0.1 mg / mL, but trace amounts of dissolution may still exist. Therefore, vitamin K1 in vitamin K1 injection has three states of existence: (1) vitamin K1 encapsulated by micelles; (2) "viscous droplets" of vitamin K1 that are directly and evenly dispersed in water because they are not dissolved; (3) "molecular" vitamin K1 that is traceably soluble in water. However, the existing dialysis method and ultrafiltration centrifugation method are unable to accurately and comprehensively measure the vitamin K1 in the above three states.
[0033] In view of this, the present invention provides a method for determining the encapsulation rate of vitamin K1 injection, which can achieve good separation of free vitamin K1 (including vitamin K1 in the state of "viscous droplets" and vitamin K1 in the state of "molecular state") and micelle-encapsulated vitamin K1 in the vitamin K1 injection, thereby achieving accurate determination of the encapsulation rate of vitamin K1 injection.
[0034] The method for determining the encapsulation efficiency of vitamin K1 injection provided by the present invention is described below by means of specific examples. In the following examples, the vitamin K1 injection used for determination is a sterile aqueous solution of vitamin K1, which is a yellow clear liquid with a specification of 1 mL: 10 mg.
[0035] Example 1
[0036] This embodiment provides a method for determining the encapsulation efficiency of vitamin K1 injection, the steps comprising:
[0037] (1) Separation step:
[0038] Measure 5 mL of vitamin K1 injection into a centrifuge tube, add 200 mg of D101 non-polar macroporous adsorption resin, vortex mix for 5 minutes, and centrifuge at 10000 r / min for 30 minutes (after centrifugation, the liquid in the centrifuge tube is divided into 3 layers, from top to bottom, namely the "viscous droplet" layer, the micelle layer and the resin layer adsorbed with "molecular" vitamin K1).
[0039] (2) Determination steps:
[0040] Measure 1 mL of the intermediate layer (micellar layer) solution and vitamin K1 injection and place them in 100 mL brown volumetric flasks, dilute to the scale with the mobile phase and shake well to obtain test solutions Ⅰ and Ⅱ, respectively.
[0041] Determine the chromatographic peak areas corresponding to the test solution Ⅰ and Ⅱ according to the following chromatographic conditions:
[0042] Chromatographic column: octadecylsilane bonded silica gel as filler (Agilent ZORBAX Eclipe XDB-C18 4.6×150mm, 5μm);
[0043] Mobile phase: anhydrous ethanol: water (volume ratio: 90:10);
[0044] Detection wavelength: 254nm;
[0045] Column temperature: 30°C;
[0046] Flow rate: 1 mL / min;
[0047] Injection volume: 10 μL;
[0048] System suitability requirements: The theoretical plate number calculated based on the vitamin K1 peak is not less than 3000.
[0049] The encapsulation efficiency of vitamin K1 injection was calculated according to the following formula (as shown in Table 1).
[0050] Encapsulation efficiency (%) = A 胶束 / A 总 ×100%,
[0051] Where: A 胶束 is the peak area of the test solution Ⅰ (corresponding to the content of vitamin K1 in the micelle layer); A 总 It is the peak area of test solution II (corresponding to the content of vitamin K1 in unseparated vitamin K1 injection).
[0052] Wherein, the preparation method of vitamin K1 injection is:
[0053] Weigh 6.0 g of glycocholic acid and 460 mg of sodium hydroxide, add them into purified water in sequence, heat and stir at 400 r / min until dissolved, add 7.56 g of soybean lecithin, stir at 400 r / min until dissolved, add 1.0 g of vitamin K1, stir at 60°C for 60 min, cool to room temperature, adjust the pH of the solution to 6.0, make up to 100 mL with purified water, fill, and sterilize at 121°C for 12 min (F0 value ≥ 12).
[0054] Example 2
[0055] This embodiment provides a method for determining the encapsulation efficiency of vitamin K1 injection, the steps comprising:
[0056] (1) Separation step:
[0057] Measure 5 mL of vitamin K1 injection into a centrifuge tube, add 400 mg of HPD-100 non-polar macroporous adsorption resin, vortex mix for 5 minutes, and centrifuge at 15000 r / min for 20 minutes (after centrifugation, the liquid in the centrifuge tube is divided into 3 layers, from top to bottom, namely the "viscous droplet" layer, the micelle layer and the resin layer adsorbed with "molecular" vitamin K1).
[0058] (2) Determination steps:
[0059] The same determination steps as in Example 1.
[0060] The preparation process of the vitamin K1 injection used in this example is the same as that in Example 1.
[0061] Example 3
[0062] This embodiment provides a method for determining the encapsulation efficiency of vitamin K1 injection, the steps comprising:
[0063] (1) Separation step:
[0064] Measure 5 mL of vitamin K1 injection into a centrifuge tube, add 800 mg of ADS-8 non-polar macroporous adsorption resin, vortex mix for 5 minutes, and centrifuge at 20,000 r / min for 15 minutes (after centrifugation, the liquid in the centrifuge tube is divided into 3 layers, from top to bottom, namely the "viscous droplet" layer, the micelle layer, and the resin layer adsorbed with "molecular" vitamin K1).
[0065] (2) Determination steps:
[0066] The same determination steps as in Example 1.
[0067] The preparation process of the vitamin K1 injection used in this example is the same as that in Example 1.
[0068] Example 4
[0069] In this embodiment, the preparation process of vitamin K1 injection is as follows:
[0070] Weigh 7.56 g of soybean lecithin and 460 mg of sodium hydroxide, add them into purified water in sequence, heat and stir at 400 r / min until dissolved, add 6.0 g of glycocholic acid, stir at 400 r / min until dissolved, add 1.0 g of vitamin K1, stir at 60°C for 45 min, cool to room temperature, adjust the pH of the solution to 6.0, make up to 100 mL with purified water, fill, and sterilize at 121°C for 12 min (F0 value ≥ 12).
[0071] Among them, the method for determining the encapsulation efficiency of vitamin K1 injection is the same as that in Example 1.
[0072] Example 5
[0073] The encapsulation efficiency of the reference preparation was determined according to the same separation and determination steps as in Example 1, wherein the manufacturer of the reference preparation was CHEPLAPHARM Arzneimittel GmbH, batch number: F4100F02.
[0074] The encapsulation efficiency of the vitamin K1 injection of each of Examples 1 to 5 was calculated, and the results are shown in Table 1.
[0075] Table 1 Encapsulation efficiency of vitamin K1 injection in Examples 1 to 5
[0076]
[0077] As can be seen from Table 1, Examples 1 to 3 are the encapsulation rate determination of vitamin K1 injection prepared by the same preparation process, and the durability of the separation step is investigated. The centrifugal speed, centrifugal time, the amount of macroporous adsorption resin added and different types of non-polar macroporous adsorption resins are varied within a certain range, and the results of the determined encapsulation rate are reproducible and can meet the experimental requirements. The preparation process of the vitamin K1 injection determined in Example 4 is different from that of Examples 1 to 3, and the determined encapsulation rate is also different, indicating that this method can guide the development of the process. Example 5 is a reference preparation, and the encapsulation rate of the reference preparation measured by the method of Example 1 is higher.
[0078] The above examples show that the method for determining the encapsulation efficiency of vitamin K1 injection provided by the present invention can be used as a means to screen and monitor the preparation process of vitamin K1 injection.
[0079] Verification Example 1
[0080] In order to verify the accuracy of the separation step in the method for determining vitamin K1 injection provided by the present invention, the inventors conducted the following experiments:
[0081] Experiment 1
[0082] Weigh 4 portions of vitamin K1 raw materials, 20 mg each, in parallel and place them in 15 mL centrifuge tubes, add 10 mL of purified water respectively, vortex mix for 5 min to evenly disperse vitamin K1 in the water, and centrifuge at 10000 r / min for 10 min, 15 min, 20 min and 30 min respectively (at this time, the liquid in the centrifuge tube is divided into 2 layers, from top to bottom, a "viscous droplet" layer and a "molecular state" layer slightly soluble in water), take the lower layer solutions respectively as test solutions I to IV, and determine the concentrations of vitamin K1 in the test solutions I to IV according to the determination steps in Example 1. The results are shown in Table 2.
[0083] Table 2
[0084] serial number <![CDATA[Vitamin K1 concentration (mg / mL)]]> Test solution Ⅰ 0.19 Test solution Ⅱ 0.09 Test solution III 0.08 Test solution IV 0.09 .
[0085] Table 2 shows that after at least 15 minutes of centrifugation, the concentration of vitamin K1 in the lower solution tends to be stable, indicating that after the above-mentioned centrifugation period, the upper layer in the "viscous droplet" state and the lower layer in the "molecular state" slightly soluble in water can be well separated.
[0086] Experiment 2
[0087] Three portions of vitamin K1 raw material, 20 mg each, were weighed in parallel and placed in 15 mL centrifuge tubes respectively. 10 mL of purified water was added respectively and vortexed for 5 min to evenly disperse vitamin K1 in the water. The mixture was centrifuged at 5000 r / min, 10000 r / min and 15000 r / min for 15 min respectively (at this time, the liquid in the centrifuge tube was divided into two layers, namely, a "viscous droplet" layer and a "molecular state" layer slightly soluble in water from top to bottom). The lower layer solutions were taken respectively as test solutions I to III, and the concentrations of vitamin K1 in the test solutions I to III were determined according to the determination steps in Example 1. The results are shown in Table 3.
[0088] Table 3
[0089]
[0090]
[0091] Table 3 shows that after centrifugation at a specific speed, the concentration of vitamin K1 in the lower solution tends to be stable, indicating that under the above centrifugal speed conditions, the upper layer of "viscous droplets" and the lower layer of "molecular state" slightly soluble in water can be well separated.
[0092] Experiment 3
[0093] Weigh 80 mg of vitamin K1 raw material and place it in a 50 mL centrifuge tube, add 40 mL of purified water, vortex mix for 5 minutes to evenly disperse the vitamin K1 in the water, and centrifuge at 10000 r / min for 15 minutes (at this time, the liquid in the centrifuge tube is divided into two layers, from top to bottom, a "viscous droplet" layer and a "molecular state" layer that is slightly soluble in water), take the lower layer solution as the test solution I and determine the concentration of vitamin K1 in the test solution I according to the determination steps in Example 1.
[0094] Three portions of test solution I, 5 ml each, were measured in parallel and placed in centrifuge tubes respectively. 100 mg, 200 mg and 400 mg of D101 non-polar macroporous adsorption resin were added respectively. The mixture was vortexed for 5 minutes (the liquid in the centrifuge tube was divided into two layers, namely, a purified water layer and an adsorption resin layer from top to bottom). The upper layer solutions were taken as test solutions II to IV respectively, and the concentrations of vitamin K1 in the test solutions II to IV were determined according to the determination steps in Example 1. The results are shown in Table 4.
[0095] Table 4
[0096] serial number <![CDATA[Vitamin K1 concentration (mg / mL)]]> Test solution Ⅰ 0.09 Test solution Ⅱ 0.02 Test solution III Not detected Test solution IV Not detected .
[0097] It can be seen from Table 4 that when the amount of adsorption resin added is 200 mg or more, vitamin K1 is not detected in the upper solution test solution III to IV after resin adsorption (the detection limit is 0.035 μg / mL), indicating that the amount of resin added can ensure that the vitamin K1 in the "molecular state" layer is completely adsorbed.
[0098] Experiment 4
[0099] Weigh 80 mg of vitamin K1 raw material and place it in a 50 mL centrifuge tube, add 40 mL of purified water, vortex mix for 5 minutes to evenly disperse the vitamin K1 in the water, and centrifuge at 10000 r / min for 15 minutes (at this time, the liquid in the centrifuge tube is divided into two layers, from top to bottom, a "viscous droplet" layer and a "molecular state" layer that is slightly soluble in water), take the lower layer solution as the test solution I and determine the concentration of vitamin K1 in the test solution I according to the determination steps in Example 1.
[0100] Four portions of test solution I, 5 mL each, were measured in parallel and placed in centrifuge tubes respectively. 200 mg each of ADS-7 polar macroporous adsorption resin, HPD-100 non-polar macroporous adsorption resin, ADS-8 non-polar macroporous adsorption resin and HJ-04 non-polar macroporous adsorption resin were added respectively. The mixture was vortexed for 5 minutes (the liquid in the centrifuge tube was divided into two layers, namely, a purified water layer and an adsorption resin layer from top to bottom). The upper layer solutions were taken as test solutions II to V, and the concentrations of vitamin K1 in the test solutions II to V were determined according to the determination steps in Example 1. The results are shown in Table 5.
[0101] Table 5
[0102] serial number <![CDATA[Vitamin K1 concentration (mg / mL)]]> Test solution Ⅰ 0.09 Test solution Ⅱ 0.08 Test solution III Not detected Test solution IV Not detected Test solution V Not detected .
[0103] Table 5 shows that the polar macroporous adsorption resin ADS-7 has almost no adsorption capacity for vitamin K1 in the "molecular state" layer.
[0104] Verification Example 2
[0105] In order to verify the accuracy of the determination step in the method for determining vitamin K1 injection provided by the present invention, the inventors conducted the following experiments:
[0106] Solution preparation:
[0107] Blank solvent: mobile phase;
[0108] Blank excipient solution: weigh about 75.6 mg of excipient soybean lecithin, about 60 mg of glycocholic acid, and about 4.6 mg of sodium hydroxide, accurately weigh, place in a 100 mL brown volumetric flask, add blank solvent to dissolve and dilute to the scale, shake well for later use;
[0109] Vitamin K1 reference solution: Accurately weigh 20 mg of vitamin K1 reference and place it in a 200 mL brown volumetric flask. Add blank solvent to dissolve and dilute to the scale. Shake well and set aside.
[0110] (I) Specificity test
[0111] The prepared blank solvent, blank auxiliary material solution and vitamin K1 reference solution were measured according to the chromatographic conditions in Example 1, and the chromatograms were as follows: Figures 1 to 3 As shown. It can be seen that the peak positions of the blank solvent and blank excipient solution have no intersection with the peak position of the vitamin K1 reference substance, indicating that they have no interference with the determination of the vitamin K1 content, indicating that the determination method has good specificity.
[0112] (II) Sensitivity test
[0113] Take an appropriate amount of vitamin K1 reference solution, dissolve it with blank solvent and dilute it step by step, measure the signal-to-noise ratio of the vitamin K1 chromatographic peak step by step, and take the concentration corresponding to the signal-to-noise ratio of 10:1 as the quantitative limit concentration. Prepare 6 quantitative limit solutions in parallel, and take the concentration corresponding to the signal-to-noise ratio of 3:1 as the detection limit concentration. The determination was carried out according to the chromatographic conditions of Example 1, and the RSD was calculated based on the chromatographic peak areas of 6 times. The results are shown in Table 6.
[0114] Table 6
[0115] Limit of quantification (μg / mL) 0.125 Equivalent to the concentration of the test solution 0.125% Quantitative limit peak area -1 1881 Quantitative limit peak area -2 1834 Quantitative limit peak area -3 1857 Quantitative limit peak area -4 1996 Quantitative limit peak area -5 1942 Quantitative limit peak area -6 1904 Average peak area 1902 RSD(%) 3.11
[0116] As can be seen from Table 6, the quantitative limit of the vitamin K1 solution is 0.125 μg / mL. The solution with the quantitative limit concentration is repeatedly injected 6 times, and the RSD between the obtained chromatographic peak areas is 3.11%, which is less than 10%, indicating that the sensitivity of the determination method provided by the present invention meets the requirements.
[0117] What is described above is only a preferred specific implementation manner of the present invention, but the protection scope of the present invention is not limited thereto. Any technician familiar with the technical field can make equivalent replacements or changes according to the technical scheme and inventive concept of the present invention within the technical scope disclosed by the present invention, which should be covered by the protection scope of the present invention.
Claims
1. A method for determining the encapsulation efficiency of vitamin K1 injection, characterized in that the steps include: S1, separation step: adding a non-polar macroporous adsorption resin to the vitamin K1 injection to be tested, mixing and centrifuging, so that the vitamin K1 injection is layered from top to bottom into a "viscous droplet" layer, a micelle layer and a resin layer; S2. Determination step: Using liquid chromatography, the micellar layer and the unseparated vitamin K1 injection are measured respectively, and the area A of the chromatographic peak is 胶束 and A 总 Perform the calculation: Encapsulation efficiency (%) = A 胶束 / A 总 ×100%, A 胶束 is the chromatographic peak area of the micelle layer, A 总 is the chromatographic peak area of unseparated vitamin K1 injection.
2. The method for determining the encapsulation efficiency of vitamin K1 injection according to claim 1, characterized in that: The non-polar macroporous adsorption resin is selected from at least one of D101 non-polar macroporous adsorption resin, HPD-100 non-polar macroporous adsorption resin, ADS-8 non-polar macroporous adsorption resin or HJ-04 non-polar macroporous adsorption resin.
3. The method for determining the encapsulation efficiency of vitamin K1 injection according to claim 2, characterized in that: The mass volume ratio of the non-polar macroporous adsorption resin to the vitamin K1 injection to be tested is 200-800 mg:5 mL.
4. The method for determining the encapsulation efficiency of vitamin K1 injection according to claim 1, characterized in that: Vortex to mix.
5. The method for determining the encapsulation efficiency of vitamin K1 injection according to claim 1, characterized in that: The centrifugation time is at least 15 minutes.
6. The method for determining the encapsulation efficiency of vitamin K1 injection according to claim 5, characterized in that: The rotation speed during the centrifugation is 10000-20000 r / min.
7. The method for determining the encapsulation efficiency of vitamin K1 injection according to claim 1, characterized in that: The resin layer adsorbs "molecular" vitamin K1 that is slightly soluble in water.
8. The method for determining the encapsulation efficiency of vitamin K1 injection according to claim 1, characterized in that: The liquid chromatography method adopts the following chromatographic conditions: Chromatographic column: C18 column; Mobile phase: anhydrous ethanol: water = 90:10, v / v; Detection wavelength: 254nm; Column temperature: 30°C; Flow rate: 1 mL / min; Injection volume: 10 μL.
9. The method for determining the encapsulation efficiency of vitamin K1 injection according to claim 8, characterized in that: The model of the C18 chromatographic column is Agilent ZORBAX Eclipe XDB-C18, 4.6×150 mm, 5 μm.
10. Use of the method for determining the encapsulation efficiency of vitamin K1 injection according to any one of claims 1 to 9 in screening and monitoring the preparation process of vitamin K1 injection.
Citation Information
Cited By
Vitamin K1 micelle encapsulation efficiency determination method
CN120948644A
